Our ultimate goal is to combine our experimental and clinical research into a translational approach. The key to our translational research is the conduction of investigator-initiated clinical trials to test novel and more patient-personalized treatments. To that end we have developed novel methodologies that discriminate patients at risk of developing autoimmune diseases and identify biomarkers for treatment response. Also very much embedded within this topic, check our latest review on JAKinibs a family of drugs that could greatly benefit to precision medicine in rheumatology.